Efficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials.

Domenica RubinoHanna AngeleneAnthony FabricatoreJamy D Ard

Published in: Obesity (Silver Spring, Md.) (2024)

The treatment effect of semaglutide was statistically significant versus placebo and clinically relevant across all racial and ethnic subgroups in STEP 1 and 3 and STEP 2. All subgroups across both samples demonstrated good tolerability.

Keyphrases

randomized controlled trial
double blind
open label
placebo controlled
combination therapy
african american
phase iii